News
06-06-2011, 10:11 PM
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced updated data from its Phase 2 clinical trial of NeuVax at the American Society of Clinical Oncology (ASCO) annual meeting.
More... (http://www.news-medical.net/news/20110607/Positive-results-from-RXi-NeuVax-Phase-2-trial-on-breast-cancer-presented-at-ASCO-2011.aspx)
More... (http://www.news-medical.net/news/20110607/Positive-results-from-RXi-NeuVax-Phase-2-trial-on-breast-cancer-presented-at-ASCO-2011.aspx)